However, Tet1 deficiency in ESCs did not abrogate pluripotency [12], and on the contrary, the deletion in HSCs enhances potential self-renewal capacity [13], reminiscent of the deletion of Tet2. HSCs are considered to be one of major target cells of driver mutation(s) that initiate AML [19]. Here, TET1 is linked to acute myeloid leukemia.